Your session is about to expire
← Back to Search
Intravascular Lithotripsy
Intravascular Lithotripsy for Peripheral Arterial Disease
N/A
Waitlist Available
Research Sponsored by Shockwave Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Up to 2 below-the-knee target lesion(s) in native vessels in one or both limbs
Age of subject is ≥ 18
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
Study Summary
This trial is designed to study the safety and effectiveness of the Shockwave Medical Peripheral IVL System for the treatment of calcified, stenotic BTK arteries.
Who is the study for?
Adults over 18 with Peripheral Arterial Disease affecting the legs, specifically below-the-knee arteries. Participants must have a life expectancy over a year and be able to follow study procedures. They should have moderate to severe artery calcification or non-dilatable lesions, and not be allergic to certain materials like urethane or silicone.Check my eligibility
What is being tested?
The trial is testing the Shockwave Medical Peripheral IVL System's safety and effectiveness in treating calcified, narrowed arteries below the knee. It's an observational study where all participants receive Intravascular Lithotripsy (IVL) without being compared to another group.See study design
What are the potential side effects?
While specific side effects are not listed here, similar procedures may include discomfort at the treatment site, bruising, bleeding, potential for artery damage or disruption of plaque that could block blood flow elsewhere.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have up to 2 lesions below the knee in my legs.
Select...
I am 18 years old or older.
Select...
I have up to 2 target lesions below the knee in my legs.
Select...
My leg has severe blockage and pain from the knee to the ankle.
Select...
My cancer lesion is 200 mm or smaller.
Select...
I have good blood flow in at least one foot artery.
Select...
My heart's blood vessels have moderate to severe calcium buildup.
Select...
My leg has severe circulation problems, classified as Rutherford 3-5.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Major Adverse Limb Events (MALE) + Post-Operative Death (POD)
Procedure Success
Secondary outcome measures
Ankle-brachial index (ABI) or toe-brachial index (TBI)
Clinically Relevant Target Lesion Failure (CR-TLF)
Lesion Success
+5 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Single-armExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Shockwave Medical, Inc.Lead Sponsor
28 Previous Clinical Trials
7,916 Total Patients Enrolled
10 Trials studying Peripheral Arterial Disease
2,041 Patients Enrolled for Peripheral Arterial Disease
Media Library
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger